A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Males or females ≥ 50 years of age at the time of signing the informed consent. [+10]
Female trial participant who is pregnant or breastfeeding. [+11]